Cellular prion protein regulates its ownα-cleavage through ADAM8 in skeletal muscle

Journal of Biological Chemistry

Volumn 287, Issue 20, 2012, Pages 16510-16520

  Liang, Jingjing ^a   Wang, Wei ^a,d   Sorensen, Debra ^c   Medina, Sarah ^c   Ilchenko, Sergei ^b   Kiselar, Janna ^b   Surewicz, Witold K ^b   Booth, Stephanie A ^c   Kong, Qingzhong ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; MAMMALS; PRASEODYMIUM COMPOUNDS; PROTEINS;

CELLULAR PRION PROTEINS; MUSCLE CELL; MYOBLAST CELLS; OVER-EXPRESSION; PROTEIN LEVEL; SKELETAL MUSCLE; TRANSGENIC MICE; UP-REGULATION;

MUSCLE;

ADAM PROTEIN; PRION PROTEIN; PROTEIN ADAM8; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; MUSCLE TISSUE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SKELETAL MUSCLE; UPREGULATION;

MUS; MUS MUSCULUS;

EID: 84860864336     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.360891     Document Type: Article

References (81)

1. Miele, G., Alejo Blanco A. R., Baybutt, H., Horvat, S., Manson, J., and Clinton, M. (2003) Embryonic activation and developmental expression of the murine prion protein gene. Gene Expr. 11, 1-12 (Pubitemid 36395880)
2. Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. U.S.A. 95, 13363-13383
3. Laurén, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W., and Strittmatter, S. M. (2009) Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers. Nature 457, 1128-1132
4. Gimbel, D. A., Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M. (2010) Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367-6374
5. Kessels, H. W., Nguyen, L. N., Nabavi, S., and Malinow, R. (2010) The prion protein as a receptor for amyloid-β. Nature 466, E3-4
6. Mehrpour, M., and Codogno, P. (2010) Prion protein: From physiology to cancer biology. Cancer. Lett. 290, 1-23
7. Aguzzi, A., Baumann, F., and Bremer, J. (2008) The prion's elusive reason for being. Annu. Rev. Neurosci. 31, 439-477
8. Linden, R., Martins, V. R., Prado, M. A., Cammarota, M., Izquierdo, I., and Brentani, R. R. (2008) Physiology of the prion protein. Physiol. Rev. 88, 673-728 (Pubitemid 351520090)
9. Westergard, L., Christensen, H. M., and Harris, D. A. (2007) The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim. Biophys. Acta 1772, 629-644 (Pubitemid 46880208)
10. Sorgato, M. C., Peggion, C., and Bertoli, A. (2009) Is, indeed, the prion protein a Harlequin servant of "many" masters? Prion 3, 202-205
11. Steinacker, P., Hawlik, A., Lehnert, S., Jahn, O., Meier, S., Görz, E., Braunstein, K. E., Krzovska, M., Schwalenstöcker, B., Jesse, S., Pröpper, C., Böckers, T., Ludolph, A., and Otto, M. (2010) Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis. Am. J. Pathol. 176, 1409-1420
12. Pauly, P. C., and Harris, D. A. (1998) Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273, 33107-33110 (Pubitemid 29005676)
13. Singh, A., Kong, Q., Luo, X., Petersen, R. B., Meyerson, H., and Singh, N. (2009) Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport. PLoS One 4, e6115
14. Jiménez-Huete, A., Lievens, P. M., Vidal, R., Piccardo, P., Ghetti, B., Tagliavini, F., Frangione, B., and Prelli, F. (1998) Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. Am. J. Pathol. 153, 1561-1572 (Pubitemid 28509913)
15. Chen, S. G., Teplow, D. B., Parchi, P., Teller, J. K., Gambetti, P., and Autilio- Gambetti, L. (1995) Truncated forms of the human prion protein in normal brain and in prion diseases. J. Biol. Chem. 270, 19173-19180
16. Owen, J. P., Rees, H. C., Maddison, B. C., Terry, L. A., Thorne, L., Jackman, R., Whitelam, G. C., and Gough, K. C. (2007) Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments. J. Virol. 81, 10532-10539 (Pubitemid 47463326)
17. Dron, M., Moudjou, M., Chapuis, J., Salamat, M. K., Bernard, J., Cronier, S., Langevin, C., and Laude, H. (2010) Endogenous proteolytic cleavage of disease-associated prion protein to produce C2 fragments is strongly celland tissue-dependent. J. Biol. Chem. 285, 10252-10264
18. Yadavalli, R., Guttmann, R. P., Seward, T., Centers, A. P., Williamson, R. A., and Telling, G. C. (2004) Calpain-dependent endoproteolytic cleavage of PrPSc modulates scrapie prion propagation. J. Biol. Chem. 279, 21948-21956 (Pubitemid 38679385)
19. Pan, K. M., Stahl, N., and Prusiner, S. B. (1992) Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci. 1, 1343-1352 (Pubitemid 23009228)
20. Taraboulos, A., Raeber, A. J., Borchelt, D. R., Serban, D., and Prusiner, S. B. (1992) Synthesis and trafficking of prion proteins in cultured cells. Mol. Biol. Cell 3, 851-863 (Pubitemid 23079759)
21. Mangé, A., Béranger, F., Peoc'h, K., Onodera, T., Frobert, Y., and Lehmann, S. (2004) α- and β-cleavages of the amino-terminus of the cellular prion protein. Biol. Cell 96, 125-132
22. Gasset, M., Baldwin, M. A., Lloyd, D. H., Gabriel, J. M., Holtzman, D. M., Cohen, F., Fletterick, R., and Prusiner, S. B. (1992) Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid. Proc. Natl. Acad. Sci. U.S.A. 89, 10940-10944
23. Forloni, G., Angeretti, N., Chiesa, R., Monzani, E., Salmona, M., Bugiani, O., and Tagliavini, F. (1993) Neurotoxicity of a prion protein fragment. Nature 362, 543-546 (Pubitemid 23113029)
24. Jobling, M. F., Stewart, L. R., White, A. R., McLean, C., Friedhuber, A., Maher, F., Beyreuther, K., Masters, C. L., Barrow, C. J., Collins, S. J., and Cappai, R. (1999) The hydrophobic core sequence modulates the neurotoxic and secondary structure properties of the prion peptide 106-126. J. Neurochem. 73, 1557-1565 (Pubitemid 29440157)
25. Norstrom, E. M., and Mastrianni, J. A. (2005) The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation. J. Biol. Chem. 280, 27236-27243 (Pubitemid 41040763)
26. McMahon, H. E., Mangé, A., Nishida, N., Créminon, C., Casanova, D., and Lehmann, S. (2001) Cleavage of the amino terminus of the prion protein by reactive oxygen species. J. Biol. Chem. 276, 2286-2291 (Pubitemid 32109714)
27. Watt, N. T., Taylor, D. R., Gillott, A., Thomas, D. A., Perera, W. S., and Hooper, N. M. (2005) Reactive oxygen species-mediated β-cleavage of the prion protein in the cellular response to oxidative stress. J. Biol. Chem. 280, 35914-35921 (Pubitemid 41633859)
28. Doh-Ura, K., Iwaki, T., and Caughey, B. (2000) Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation. J. Virol. 74, 4894-4897 (Pubitemid 30237920)
29. Luhr, K. M., Nordström, E. K., Löw, P., and Kristensson, K. (2004) Cathepsin B and L are involved in degradation of prions in GT1-1 neuronal cells. Neuroreport 15, 1663-1667 (Pubitemid 38971190)
30. Taguchi, Y., Shi, Z. D., Ruddy, B., Dorward, D. W., Greene, L., and Baron, G. S. (2009) Specific biarsenical labeling of cell surface proteins allows fluorescent- and biotin-tagging of amyloid precursor protein and prion proteins. Mol. Biol. Cell 20, 233-244
31. Guillot-Sestier, M. V., Sunyach, C., Druon, C., Scarzello, S., and Checler, F. (2009) The alpha-secretase-derived N-terminal product of cellular prion, N1, displays neuroprotective function in vitro and in vivo. J. Biol. Chem. 284, 35973-35986
32. Sunyach, C., Cisse, M. A., da Costa, C. A., Vincent, B., and Checler, F. (2007) The C-terminal products of cellular prion protein processing, C1 and C2, exert distinct influence on p53-dependent staurosporine-induced caspase-3 activation. J. Biol. Chem. 282, 1956-1963 (Pubitemid 47076732)
33. Mitteregger, G., Vosko, M., Krebs, B., Xiang, W., Kohlmannsperger, V., Nölting, S., Hamann, G. F., and Kretzschmar, H. A. (2007) The role of the octarepeat region in neuroprotective function of the cellular prion protein. Brain Pathol. 17, 174-183 (Pubitemid 46466137)
34. Taylor, D. R., Parkin, E. T., Cocklin, S. L., Ault, J. R., Ashcroft, A. E., Turner, A. J., and Hooper, N. M. (2009) Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J. Biol. Chem. 284, 22590-22600
35. Shyng, S. L., Huber, M. T., and Harris, D. A. (1993) A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. J. Biol. Chem. 268, 15922-15928 (Pubitemid 23222097)
36. Harris, D. A., Huber, M. T., van Dijken, P., Shyng, S. L., Chait, B. T., and Wang, R. (1993) Processing of a cellular prion protein: identification of Nand C-terminal cleavage sites. Biochemistry 32, 1009-1016 (Pubitemid 23057673)
37. Vincent, B., Paitel, E., Frobert, Y., Lehmann, S., Grassi, J., and Checler, F. (2000) Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J. Biol. Chem. 275, 35612-35616
38. Vincent, B., Paitel, E., Saftig, P., Frobert, Y., Hartmann, D., De Strooper, B., Grassi, J., Lopez-Perez, E., and Checler, F. (2001) The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J. Biol. Chem. 276, 37743-37746
39. Cissé, M. A., Sunyach, C., Lefranc-Jullien, S., Postina, R., Vincent, B., and Checler, F. (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem. 280, 40624-40631 (Pubitemid 41780553)
40. Walmsley, A. R., Watt, N. T., Taylor, D. R., Perera, W. S., and Hooper, N. M. (2009)α-cleavage of the prion protein occurs in a late compartment of the secretory pathway and is independent of lipid rafts. Mol. Cell. Neurosci. 40, 242-248
41. White, J. M. (2003) ADAMs: modulators of cell-cell and cell-matrix interactions. Curr. Opin. Cell Biol. 15, 598-606
42. Edwards, D. R., Handsley, M. M., and Pennington, C. J. (2008) The ADAM metalloproteinases. Mol. Aspects. Med. 29, 258-289
43. Moss, M. L., and Lambert, M. H. (2002) Shedding of membrane proteins by ADAM family proteases. Essays Biochem. 38, 141-153 (Pubitemid 36589200)
44. Alfa Cissé, M., Sunyach, C., Slack B. E., Fisher, A., Vincent, B., and Checler, F. (2007) M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J. Neurosci. 27, 4083-4092 (Pubitemid 46597172)
45. Laffont-Proust, I., Faucheux, B. A., Hässig, R., Sazdovitch, V., Simon, S., Grassi, J., Hauw, J. J., Moya, K. L., and Haïk, S. (2005) The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett. 579, 6333-6337 (Pubitemid 41612148)
46. Endres, K., Mitteregger, G., Kojro, E., Kretzschmar, H., and Fahrenholz, F. (2009) Influence of ADAM10 on prion protein processing and scrapie infectiosity in vivo. Neurobiol. Dis. 36, 233-241
47. Altmeppen, H. C., Prox, J., Puig, B., Kluth, M. A., Bernreuther, C., Thurm, D., Jorissen, E., Petrowitz, B., Bartsch, U., De Strooper, B., Saftig, P., and Glatzel, M. (2011) Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo. Mol. Neurodegener. 6, 36
48. Kaneko, K., Zulianello, L., Scott, M., Cooper, C. M., Wallace, A. C., James, T. L., Cohen, F. E., and Prusiner, S. B. (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. U.S.A. 94, 10069-10074
49. Telling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., and Prusiner, S. B. (1995) Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90
50. Petropoulos, C. J., Rosenberg, M. P., Jenkins, N. A., Copeland, N. G., and Hughes, S. H. (1989) The chicken skeletal muscle α-actin promoter is tissue specific in transgenic mice. Mol. Cell. Biol. 9, 3785-3792 (Pubitemid 19216273)
51. Nico, P. B., Lobão-Soares, B., Landemberger, M. C., Marques, W., Jr., Tasca, C. I., de Mello, C. F., Walz, R., Carlotti, C. G., Jr., Brentani, R. R., Sakamoto, A. C., and Bianchin, M. M. (2005) Impaired exercise capacity, but unaltered mitochondrial respiration in skeletal or cardiac muscle of mice lacking cellular prion protein. Neurosci. Lett. 388, 21-26
52. Massimino, M. L., Ferrari, J., Sorgato, M. C., and Bertoli, A. (2006) Heterogeneous PrPC metabolism in skeletal muscle cells. FEBS Lett. 580, 878-884 (Pubitemid 43152308)
53. Brown, D. R., Schmidt, B., Groschup, M. H., and Kretzschmar, H. A. (1998) Prion protein expression in muscle cells and toxicity of a prion protein fragment. Eur. J. Cell Biol. 75, 29-37 (Pubitemid 28080644)
54. Stella, R., Massimino, M. L., Sandri, M., Sorgato, M. C., and Bertoli, A. (2010) Cellular prion protein promotes regeneration of adult muscle tissue. Mol. Cell. Biol. 30, 4864-4876
55. Askanas, V., Bilak, M., Engel, W. K., Alvarez, R. B., Tomé, F., and Leclerc, A. (1993) Prion protein is abnormally accumulated in inclusion-body myositis. Neuroreport 5, 25-28 (Pubitemid 23330812)
56. Sarkozi, E., Askanas, V., and Engel, W. K. (1994) Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion- body myositis and hereditary inclusion-body myopathy. Am. J. Pathol. 145, 1280-1284 (Pubitemid 24378481)
57. Zanusso, G., Vattemi, G., Ferrari, S., Tabaton, M., Pecini, E., Cavallaro, T., Tomelleri, G., Filosto, M., Tonin, P., Nardelli, E., Rizzuto, N., and Monaco, S. (2001) Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies, and denervation atrophy. Brain Pathol. 11, 182-189 (Pubitemid 32198845)
58. Westaway, D., DeArmond, S. J., Cayetano-Canlas, J., Groth, D., Foster, D., Yang, S. L., Torchia, M., Carlson, G. A., and Prusiner, S. B. (1994) Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76, 117-129 (Pubitemid 24035286)
59. Huang, S., Liang, J., Zheng, M., Li, X., Wang, M., Wang, P., Vanegas, D., Wu, D., Chakraborty, B., Hays, A. P., Chen, K., Chen, S. G., Booth, S., Cohen, M., Gambetti, P., and Kong, Q. (2007) Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 104, 6800-6805 (Pubitemid 47175581)
60. Liang, J., Parchaliuk, D., Medina, S., Sorensen, G., Landry, L., Huang, S., Wang, M., Kong, Q., and Booth, S. A. (2009) Activation of p53-regulated pro-apoptotic signaling pathways in PrP-mediated myopathy. BMC Genomics 10, 201-216
61. Kong, Q., Huang, S., Zou, W., Vanegas, D., Wang, M., Wu, D., Yuan, J., Zheng, M., Bai, H., Deng, H., Chen, K., Jenny, A. L., O'Rourke, K., Belay, E. D., Schonberger, L. B., Petersen, R. B., Sy, M. S., Chen, S. G., and Gambetti, P. (2005) Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J. Neurosci. 25, 7944-7949 (Pubitemid 41254397)
62. Kelly, K., Hutchinson, G., Nebenius-Oosthuizen, D., Smith, A. J., Bartsch, J. W., Horiuchi, K., Rittger, A., Manova, K., Docherty, A. J., and Blobel C. P. (2005) Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice. Dev. Dyn. 232, 221-231 (Pubitemid 40070875)
63. Pan, T., Li, R., Kang, S. C., Wong, B. S., Wisniewski, T., and Sy, M. S. (2004) Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion. J. Neurochem. 90, 1205-1217 (Pubitemid 39167353)
64. Morillas, M., Swietnicki, W., Gambetti, P., and Surewicz, W. K. (1999) Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274, 36859-36865
65. Lund, C., Olsen, C. M., Tveit, H., and Tranulis, M. A. (2007) Characterization of the prion protein 3F4 epitope and its use as a molecular tag. J. Neurosci. Methods 165, 183-190 (Pubitemid 47212461)
66. Zou, W. Q., Langeveld, J., Xiao, X., Chen, S., McGeer, P. L., Yuan, J., Payne, M. C., Kang, H. E., McGeehan, J., Sy, M. S., Greenspan, N. S., Kaplan, D., Wang, G. X., Parchi, P., Hoover, E., Kneale, G., Telling, G., Surewicz, W. K., Kong, Q., and Guo, J. P. (2010) PrP conformational transitions alter species preference of a PrP-specific antibody. J. Biol. Chem. 285, 13874-13884
67. Stella, R., Massimino, M. L., Sorgato, M. C., and Bertoli, A. (2010) Prion and TNFα: TAC(E)it agreement between the prion protein and cell signaling. Cell Cycle 9, 4616-4621
68. Chen, S. E., Gerken, E., Zhang, Y., Zhan, M., Mohan, R. K., Li, A. S., Reid, M. B., and Li, Y. P. (2005) Role of TNF-{α} signaling in regeneration of cardiotoxin-injured muscle. Am. J. Physiol. Cell. Physiol. 289, C1179-C1187 (Pubitemid 41456834)
69. Chen, S. E., Jin, B., and Li, Y. P. (2007) TNF-α regulates myogenesis and muscle regeneration by activating p38 MAPK. Am. J. Physiol. Cell. Physiol. 292, C1660-C1671 (Pubitemid 47080547)
70. Zhan, M., Jin, B., Chen, S. E., Reecy, J. M., and Li, Y. P. (2007) TACE release of TNF-alpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis. J. Cell Sci. 120, 692-701 (Pubitemid 46437903)
71. Keren, A., Tamir, Y., and Bengal, E. (2006) The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252, 224-230
72. Zetser, A., Gredinger, E., and Bengal, E. (1999) p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274, 5193-5200
73. Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H., and Bartsch, J. W. (2000) Tumor necrosis factor α induces a metalloproteasedisintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J. Neurosci. 20, 7964-7971
74. Bartsch, J. W., Wildeboer, D., Koller, G., Naus, S., Rittger, A., Moss, M. L., Minai, Y., and Jockusch, H. (2010) Tumor necrosis factor-α (TNF-α) regulates shedding of TNF-α receptor 1 by the metalloprotease-disintegrin ADAM8: evidence for a protease-regulated feedback loop in neuroprotection. J. Neurosci. 30, 12210-12218
75. Pradines, E., Loubet, D., Mouillet-Richard, S., Manivet, P., Launay, J. M., Kellermann, O., and Schneider, B. (2009) Cellular prion protein coupling to TACE-dependent TNF-α shedding controls neurotransmitter catabolism in neuronal cells. J. Neurochem. 110, 912-923
76. Paitel, E., Alves da Costa, C., Vilette, D., Grassi, J., and Checler, F. (2002) Overexpression of PrPc triggers caspase 3 activation: potentiation by proteasome inhibitors and blockade by anti-PrP antibodies. J. Neurochem. 83, 1208-1214 (Pubitemid 35397130)
77. Paitel, E., Fahraeus, R., and Checler, F. (2003) Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53- dependent caspase 3-like activation. J. Biol. Chem. 278, 10061-10066 (Pubitemid 36800261)
78. Paitel, E., Sunyach, C., Alves da Costa, C., Bourdon, J. C., Vincent, B., and Checler, F. (2004) Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels. J. Biol. Chem. 279, 612-618 (Pubitemid 38044865)
79. Zhang, Y., Qin, K., Wang, J., Hung, T., and Zhao, R. Y. (2006) Dividing roles of prion protein in staurosporine-mediated apoptosis. Biochem. Biophys. Res. Commun. 349, 759-768 (Pubitemid 44344579)
80. Gougoumas, D. D., Vizirianakis, I. S., Triviai, I. N., and Tsiftsoglou, A. S. (2007) Activation of Prn-p gene and stable transfection of Prn-p cDNA in leukemia MEL and neuroblastoma N2a cells increased production of PrP(C) but not prevented DNA fragmentation initiated by serum deprivation. J. Cell. Physiol. 211, 551-559 (Pubitemid 46580109)
81. Westergard, L., Turnbaugh, J. A., and Harris, D. A. (2011) A naturally occurring C-terminal fragment of the prion protein (PrP) delays disease and acts as a dominant-negative inhibitor of PrPSc formation. J. Biol. Chem. 286, 44234-44242